Navigation Links
Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
Date:7/30/2008

l and information management solutions include, among others, Leksell Gamma Knife(R) for non-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery, and the MOSAIQ(R) suite of software for image enabled EMR and efficient management of clinical and patient data.

With around 2,500 employees globally, the corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at http://www.elekta.com .

About the Swedish Cancer Institute

The Swedish Cancer Institute (SCI) opened in 1932 as the first dedicated cancer-care center west of the Mississippi. Now in its 75th year, it is the largest and most comprehensive cancer treatment program in the Pacific Northwest. A true multidisciplinary program, SCI offers a wide range of advanced cancer-treatment options in chemotherapy, radiation therapy and surgery -- backed by extensive diagnostic capabilities, patient education and support-group services. SCI's clinical-research arm encompasses industry-sponsored and cooperative group therapeutic trials, cancer screening and prevention trials, and investigator-initiated trials. Breast-cancer screening and diagnostics are available through the Swedish Breast Care Centers and mobile mammography units. For more information, visit http://www.swedish.org .

About the Center for Advanced Targeted Radiation Therapies

The Swedish Cancer Institute's Center for Advanced Targeted Radiation Therapies encompasses the comprehensive and complimentary array of advanced and emerging radiation delivery tools available to patients for both approved therapies and clinical research efforts. They include a variety of technologies, including Intensity-Modulated Radiation Therapy (
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
2. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
3. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
4. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
5. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
6. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
7. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
8. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
9. New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer
10. Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer
11. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... SOLON, Ohio, Dec. 16 HDT Engineered ... next generation technologies and a principal subcontractor for ... (MPL), led development of new anthropromorphic arm technology ... a prosthetic arm and hand, including a sense ... Defense Advanced Research Projects Agency (DARPA) Revolutionizing Prosthetics ...
(Date:12/16/2009)... 16 A new application ... the clinical review of specialty pharmaceuticals has increased ... drugs reviewed while reducing costs. ,, AIM, a ... with health plan clients representing over 35 million ... (NYSE: WLP ), adapted the successful ...
(Date:12/16/2009)... Dec. 16 EuroPharma, Inc. signs ... the use of super absorbency BCM-95® curcumin ... formulations. The exclusive distribution territory for ... food store channel and professional channel, which ... clinics. BCM-95® is a highly absorbable ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Researcher says microchannels could advance tissue engineering methods 9601 1Researcher says microchannels could advance tissue engineering methods 9601 2Researcher says microchannels could advance tissue engineering methods 9601 3Researcher says microchannels could advance tissue engineering methods 9601 4Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 1Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 2Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 3Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024 54657 4Chicago Mayor Honors Astellas Excellence in Learning Development 54654 1Chicago Mayor Honors Astellas Excellence in Learning Development 54654 2
... - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces that ... trial of ZIO-201 (isophosphoramide mustard,- IPM) to ... the,European Society of Medical Oncology (ESMO) meeting ... abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) In ...
... Late-breaking Phase III,clinical trial data presented today ... Haemostasis (ISTH) Congress demonstrate,that once-daily rivaroxaban achieved ... (VTE) in patients undergoing,knee replacement surgery in ... of care. Patients in the RECORD3,(REgulation of ...
Other Medicine Technology:Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
(Date:12/16/2009)... 16, 2009 -- Every year in the United States, ... patients die of the disease, making it the second ... lung cancer. , As researchers and clinicians fervently look ... generating thousands of studies producing more and more promising ... cancer and genetics at Case Western Reserve University School ...
(Date:12/16/2009)... WASHINGTON, Dec. 16 Losing has never felt ... knows maintaining his healthy new lifestyle means continuing to ... Drinking fat free milk is one healthy choice that ... a simple step everyone can take. Every glass of ... muscle, potassium to help maintain normal blood pressure, and ...
(Date:12/16/2009)... most widely used human embryonic stem cell lines lack ... that must be addressed to ensure that all sectors ... a University of Michigan research team. ,, In the ... analyzed 47 embryonic stem cell lines, including most of ... scientists determined the genetic ancestry of each line and ...
(Date:12/16/2009)... long-term goal, researchers say , , WEDNESDAY, Dec. 16 ... predict whether a patient will suffer a second stroke ... is an important new tool because studies have shown ... a first stroke are more likely to die or ... Hospital and Harvard Medical School, said in an American ...
(Date:12/16/2009)... Wellcome Trust Sanger Institute announce the first comprehensive analyses ... by mutations in the DNA of cancer cells which ... a malignant melanoma and a lung cancer, reveal for ... genomes of two cancers. , Lung cancer causes around ... associated with smoking. The number of mutations found suggest ...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6
... with a second newer agent has proven to be effective ... be published in its July 7th special HIV/AIDS issue. ... 18 nations and more than 30 centers in the United ... resistant HIV the potential of receiving two investigational new drugs ...
... police inquiries as focus shifted to Australia. ... attacks in UK raided two hospitals in Western Australia and ... Indian. ,However, WA Premier Alan Carpenter said he ... ,"There is nothing that has been presented to ...
... a blood-clotting protein found in circulating blood, has been ... neuronal cells , a process that is necessary for ... ,The findings by researchers at the University ... explain why the human body is unable to repair ...
... Didrick of Naples, Florida, has come up with a fascinating ... in 150 persons do lose a digit , it is ... because it has no batteries, electronics, servos or actuators. Instead, ... the surviving part of the wearer's finger, curls a set ...
... a way to produce blood vessels by engineering tissues ... ,Researchers at the University at Buffalo Department of Chemical ... an excellent source of adult stem cells, containing smooth ... cells can be used in regenerative medicine for cardiovascular ...
... conducted by Henley Management College and the University of Milan ... age of 65 is significantly higher than it is ... study was to make the first step in the modelling ... prescribing funds. ,The research found that the mean ...
Other Medicine News:Health News:New Drugs Show Promise in Fighting Drug-Resistant HIV 2Health News:New Drugs Show Promise in Fighting Drug-Resistant HIV 3Health News:More Indian Doctors Questioned in Australia as UK Terror Plot Inquiry Widens 2Health News:Fibrinogen may Inhibit Spinal Cord Regeneration 2Health News:A Mechanical Prosthetic Close to the Real Thing 2Health News:New Blood Vessels can Be Created from Bone Marrow Stem Cells: Study 2
Blunt tipped forceps with long thin tips (3 mm) angled at approximately 120. For grasping of subretinal membranes. Color Coding: Gold....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
Microforceps: Claes ILM Forceps...
0,6 mm (23 gauge) blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
Medicine Products: